NO980055D0 - Antisoppmiddel, forbindelse derfor og fremgangsmåte for fremstilling derav - Google Patents

Antisoppmiddel, forbindelse derfor og fremgangsmåte for fremstilling derav

Info

Publication number
NO980055D0
NO980055D0 NO980055A NO980055A NO980055D0 NO 980055 D0 NO980055 D0 NO 980055D0 NO 980055 A NO980055 A NO 980055A NO 980055 A NO980055 A NO 980055A NO 980055 D0 NO980055 D0 NO 980055D0
Authority
NO
Norway
Prior art keywords
compound
preparation
antifungal agent
antifungal
agent
Prior art date
Application number
NO980055A
Other languages
English (en)
Other versions
NO980055L (no
Inventor
Hiroki Kodama
Yoshimi Niwano
Kazuo Kanai
Masanori Yoshida
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of NO980055D0 publication Critical patent/NO980055D0/no
Publication of NO980055L publication Critical patent/NO980055L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO980055A 1995-07-08 1998-01-06 Antisoppmiddel, forbindelse derfor og fremgangsmåte for fremstilling derav NO980055L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19617495 1995-07-08
PCT/JP1996/001872 WO1997002821A2 (en) 1995-07-08 1996-07-05 Antifungal agent, compound therefor, process for producing the same

Publications (2)

Publication Number Publication Date
NO980055D0 true NO980055D0 (no) 1998-01-06
NO980055L NO980055L (no) 1998-03-06

Family

ID=16353435

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980055A NO980055L (no) 1995-07-08 1998-01-06 Antisoppmiddel, forbindelse derfor og fremgangsmåte for fremstilling derav

Country Status (22)

Country Link
US (1) US5900488A (no)
EP (1) EP0839035B1 (no)
KR (1) KR100386491B1 (no)
CN (1) CN1091596C (no)
AT (1) AT407832B (no)
CA (1) CA2226214C (no)
CH (1) CH692045A5 (no)
DE (1) DE19681478B4 (no)
DK (1) DK176599B1 (no)
ES (1) ES2137888B1 (no)
FI (1) FI119357B (no)
GB (1) GB2317615B (no)
HK (1) HK1009751A1 (no)
IL (1) IL122618A (no)
IN (1) IN185384B (no)
LU (1) LU90190B1 (no)
NO (1) NO980055L (no)
NZ (1) NZ311796A (no)
SE (1) SE9800016L (no)
TW (1) TW450969B (no)
WO (1) WO1997002821A2 (no)
ZA (1) ZA965745B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127397A (en) * 1996-12-10 2000-10-03 Nihon Nohyaku Co., Ltd. Optically active (R)-(E)-(4-substituted-phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylaceto nitrile derivative, antifungal composition comprising the same, and method for producing the same
JPWO2003105903A1 (ja) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 抗真菌医薬組成物
CA2489854A1 (en) * 2002-06-18 2003-12-24 Pola Chemical Industries Inc. Antifungal medicinal compositions
EP2005959B1 (en) * 2006-03-08 2015-01-21 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
US8268876B2 (en) * 2006-03-08 2012-09-18 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
MX2008011435A (es) 2006-03-08 2009-02-03 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
KR101184834B1 (ko) 2007-08-27 2012-09-20 니혼노야쿠가부시키가이샤 진균성 피부염용제
US20100204293A1 (en) 2007-09-05 2010-08-12 Pola Pharma Inc. Pharmaceutical composition
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
US20100173965A1 (en) 2007-09-05 2010-07-08 Pola Pharma Inc. Antifungal composition
US8193232B2 (en) * 2009-02-13 2012-06-05 Topica Pharmaceuticals, Inc. Anti-fungal formulation
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102387785B (zh) 2009-04-09 2017-08-25 宝丽制药股份有限公司 抗真菌药物组合物
KR101754697B1 (ko) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 항진균성 약제학적 조성물
JP5832451B2 (ja) 2010-06-11 2015-12-16 株式会社ポーラファルマ 抗真菌医薬組成物
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
WO2014041846A1 (en) * 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
EP2895479A1 (en) * 2012-09-14 2015-07-22 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
WO2014042231A1 (en) * 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
JP6254597B2 (ja) * 2013-01-28 2017-12-27 株式会社ポーラファルマ カンジダ等の病原微生物による疾患用の医薬組成物
EP2948145A1 (en) * 2013-01-28 2015-12-02 Pola Pharma Inc. Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
WO2015162271A1 (en) * 2014-04-25 2015-10-29 Syngenta Participations Ag Microbiocidal imidazole derivatives
WO2016092478A1 (en) 2014-12-12 2016-06-16 Glenmark Pharmaceuticals Limited Process for preparation of luliconazole
WO2017108972A1 (en) 2015-12-21 2017-06-29 Laboratorios Lesvi, S.L. Compounds of r-(-)-(e)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1 -imidazolylacetonitrile-ha (luliconazole-ha) as antifungals
CN106008166B (zh) * 2016-05-17 2018-09-25 上海福乐医药科技有限公司 一种手性2-氯-1-(2,4-二氯苯基)乙醇的工业化生产方法
EP3558304A2 (en) 2016-12-23 2019-10-30 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibitors of cytochrome p450 family 7 subfamily b member 1 (cyp7b1) for use in treating diseases
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
US10898470B1 (en) 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
WO2023131969A1 (en) * 2022-01-09 2023-07-13 Kimia Biosciences Limited Improved process for the preparation of luliconazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218736B1 (en) * 1985-10-10 1993-04-07 Nihon Nohyaku Co., Ltd. A ketene s,s-acetal derivative, a process for manufacturing thereof and a method for curing mycosis by administering it
ATE87920T1 (de) * 1985-10-09 1993-04-15 Nihon Nohyaku Co Ltd Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate.
JP3030780B2 (ja) * 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH0386337A (ja) * 1989-08-28 1991-04-11 Maeda Seisakusho:Kk エクスパンディングチャックを用いた多重巻締め機および多重巻締め方法
CN1038247C (zh) * 1990-05-16 1998-05-06 云南省建筑材料科学研究设计院 一种新型磷石膏胶结料
JP3038519B2 (ja) * 1992-01-28 2000-05-08 日本農薬株式会社 創傷治癒促進剤

Also Published As

Publication number Publication date
TW450969B (en) 2001-08-21
KR100386491B1 (ko) 2003-08-21
KR19990028772A (ko) 1999-04-15
DK176599B1 (da) 2008-10-27
US5900488A (en) 1999-05-04
FI119357B (fi) 2008-10-31
AU6319296A (en) 1997-02-10
DK1398A (da) 1998-01-07
GB2317615A (en) 1998-04-01
IL122618A (en) 2002-07-25
GB9726766D0 (en) 1998-02-18
WO1997002821A2 (en) 1997-01-30
CH692045A5 (de) 2002-01-15
FI980023A0 (fi) 1998-01-07
IL122618A0 (en) 1998-08-16
CA2226214C (en) 2007-04-17
FI980023A (fi) 1998-01-07
AU697571B2 (en) 1998-10-08
HK1009751A1 (en) 1999-06-11
CN1091596C (zh) 2002-10-02
DE19681478T1 (de) 1998-07-02
LU90190B1 (de) 1998-03-02
EP0839035A2 (en) 1998-05-06
WO1997002821A3 (en) 1997-02-20
ZA965745B (en) 1997-01-27
AT407832B (de) 2001-06-25
MX9710401A (es) 1998-07-31
CN1194582A (zh) 1998-09-30
GB2317615B (en) 1998-09-02
NZ311796A (en) 1999-06-29
NO980055L (no) 1998-03-06
EP0839035B1 (en) 2002-10-02
CA2226214A1 (en) 1997-01-30
ATA906196A (de) 2000-11-15
ES2137888B1 (es) 2001-01-01
SE9800016D0 (sv) 1998-01-07
DE19681478B4 (de) 2006-09-21
ES2137888A1 (es) 1999-12-16
IN185384B (no) 2001-01-13
SE9800016L (sv) 1998-01-07

Similar Documents

Publication Publication Date Title
NO980055D0 (no) Antisoppmiddel, forbindelse derfor og fremgangsmåte for fremstilling derav
NO960772D0 (no) Naftylforbindelser og fremgangsmåte for fremstilling derav, mellomprodukter og preparater
NO950425L (no) Antifungale midler, fremgangsmåter for fremstilling av disse, og mellomprodukter
NO974572D0 (no) Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
NO20035726D0 (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
DK0799052T3 (da) Ny antihrombotisk formulering, fremgangsmåde til dens fremstilling og anvendelse deraf
PL313633A1 (en) Ceramid type compounds, method of obtaining them and their application
NO993288D0 (no) Antimikrobiell handske og fremgangsmÕte for fremstilling derav
NO20003070L (no) Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav
PL325322A1 (en) Novel substituted amine compounds, method of obtaining them and therapeutic agent
NO980257D0 (no) Forankringsinnretning, og fremgangsmåte ved forankring
NO20002181D0 (no) Steriliseringsinnpakning, anvendelse derav og fremgangsmÕte for sterilisering
EE03351B1 (et) Meetod lerkanidipiinhüdrokloriidi valmistamiseks
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
PL318114A1 (en) Novel chemical compound, method of obtaining same and application thereof as a therapeutic agent
NO940634L (no) Antiulcusmiddel og fremgangsmåte for fremstilling derav
NO982234D0 (no) Pesticidforbindelser, preparater og fremgangsmÕte for fremstilling av slike
PL325632A1 (en) Derivatives of pyrizin-2-one, their application and intermediate compounds for obtaining them
DK0722658T3 (da) Lagerstabil biocid sammensætning og fremgangsmåde til fremstilling heraf
PL312209A1 (en) Novel compounds of seccomacrolydes and seccoazalydes class, intermediate compounds and method of obtaining them
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
PL329053A1 (en) Novel derivatives of oxazolydine, method of obtaining them and therapeutic agents containing such compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application